nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Megacolon—Methotrexate—systemic scleroderma	0.0195	0.0195	CcSEcCtD
Lincomycin—Serum sickness—Captopril—systemic scleroderma	0.0194	0.0194	CcSEcCtD
Lincomycin—Vesiculobullous rash—Mycophenolic acid—systemic scleroderma	0.0128	0.0128	CcSEcCtD
Lincomycin—Azotaemia—Lisinopril—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Lincomycin—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.0113	0.0113	CcSEcCtD
Lincomycin—Azotaemia—Mycophenolate mofetil—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Lincomycin—Proteinuria—Captopril—systemic scleroderma	0.0104	0.0104	CcSEcCtD
Lincomycin—Protein urine present—Captopril—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Lincomycin—Vesiculobullous rash—Mycophenolate mofetil—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Lincomycin—Glossitis—Captopril—systemic scleroderma	0.0099	0.0099	CcSEcCtD
Lincomycin—Oliguria—Captopril—systemic scleroderma	0.0099	0.0099	CcSEcCtD
Lincomycin—Abscess—Leflunomide—systemic scleroderma	0.0095	0.0095	CcSEcCtD
Lincomycin—Abscess—Mycophenolic acid—systemic scleroderma	0.00906	0.00906	CcSEcCtD
Lincomycin—Rash pustular—Mycophenolic acid—systemic scleroderma	0.00899	0.00899	CcSEcCtD
Lincomycin—Oliguria—Mycophenolic acid—systemic scleroderma	0.00778	0.00778	CcSEcCtD
Lincomycin—Colitis—Azathioprine—systemic scleroderma	0.00764	0.00764	CcSEcCtD
Lincomycin—Leukocytosis—Mycophenolic acid—systemic scleroderma	0.00763	0.00763	CcSEcCtD
Lincomycin—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00747	0.00747	CcSEcCtD
Lincomycin—Proteinuria—Lisinopril—systemic scleroderma	0.00735	0.00735	CcSEcCtD
Lincomycin—Protein urine present—Lisinopril—systemic scleroderma	0.00725	0.00725	CcSEcCtD
Lincomycin—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.00724	0.00724	CcSEcCtD
Lincomycin—Colitis—Leflunomide—systemic scleroderma	0.00722	0.00722	CcSEcCtD
Lincomycin—Pancytopenia—Pentoxifylline—systemic scleroderma	0.00717	0.00717	CcSEcCtD
Lincomycin—Abscess—Mycophenolate mofetil—systemic scleroderma	0.00715	0.00715	CcSEcCtD
Lincomycin—Rash pustular—Mycophenolate mofetil—systemic scleroderma	0.00709	0.00709	CcSEcCtD
Lincomycin—Oliguria—Lisinopril—systemic scleroderma	0.00701	0.00701	CcSEcCtD
Lincomycin—Dermatitis bullous—Captopril—systemic scleroderma	0.00693	0.00693	CcSEcCtD
Lincomycin—Colitis—Mycophenolic acid—systemic scleroderma	0.00688	0.00688	CcSEcCtD
Lincomycin—Leukocytosis—Lisinopril—systemic scleroderma	0.00687	0.00687	CcSEcCtD
Lincomycin—Oesophagitis—Leflunomide—systemic scleroderma	0.00687	0.00687	CcSEcCtD
Lincomycin—Hepatic function abnormal—Azathioprine—systemic scleroderma	0.00661	0.00661	CcSEcCtD
Lincomycin—Jaundice—Pentoxifylline—systemic scleroderma	0.00656	0.00656	CcSEcCtD
Lincomycin—Oesophagitis—Mycophenolic acid—systemic scleroderma	0.00655	0.00655	CcSEcCtD
Lincomycin—Oliguria—Mycophenolate mofetil—systemic scleroderma	0.00614	0.00614	CcSEcCtD
Lincomycin—Glossitis—Mycophenolate mofetil—systemic scleroderma	0.00614	0.00614	CcSEcCtD
Lincomycin—Phlebitis—Mycophenolic acid—systemic scleroderma	0.00604	0.00604	CcSEcCtD
Lincomycin—Leukocytosis—Mycophenolate mofetil—systemic scleroderma	0.00602	0.00602	CcSEcCtD
Lincomycin—Azotaemia—Methotrexate—systemic scleroderma	0.00602	0.00602	CcSEcCtD
Lincomycin—Dermatitis bullous—Mycophenolic acid—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Lincomycin—Pancytopenia—Captopril—systemic scleroderma	0.00543	0.00543	CcSEcCtD
Lincomycin—Colitis—Mycophenolate mofetil—systemic scleroderma	0.00543	0.00543	CcSEcCtD
Lincomycin—Hepatic function abnormal—Lisinopril—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Lincomycin—Neutropenia—Captopril—systemic scleroderma	0.00535	0.00535	CcSEcCtD
Lincomycin—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00531	0.00531	CcSEcCtD
Lincomycin—Oesophagitis—Mycophenolate mofetil—systemic scleroderma	0.00517	0.00517	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Lincomycin—Liver function test abnormal—Leflunomide—systemic scleroderma	0.00504	0.00504	CcSEcCtD
Lincomycin—Stomatitis—Captopril—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Lincomycin—Jaundice—Captopril—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Lincomycin—Abscess—Prednisone—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Lincomycin—Angioedema—Pentoxifylline—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Lincomycin—Liver function test abnormal—Mycophenolic acid—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Lincomycin—Abdominal discomfort—Azathioprine—systemic scleroderma	0.00479	0.00479	CcSEcCtD
Lincomycin—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.00477	0.00477	CcSEcCtD
Lincomycin—Agranulocytosis—Captopril—systemic scleroderma	0.00476	0.00476	CcSEcCtD
Lincomycin—Thrombophlebitis—Mycophenolate mofetil—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Lincomycin—Pancytopenia—Azathioprine—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Lincomycin—Leukopenia—Pentoxifylline—systemic scleroderma	0.00471	0.00471	CcSEcCtD
Lincomycin—Pancytopenia—Leflunomide—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Lincomycin—Neutropenia—Leflunomide—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Lincomycin—Erythema multiforme—Captopril—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Lincomycin—Dermatitis bullous—Mycophenolate mofetil—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Lincomycin—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Lincomycin—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Lincomycin—Shock—Pentoxifylline—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Lincomycin—Neutropenia—Mycophenolic acid—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Lincomycin—Agranulocytosis—Azathioprine—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Lincomycin—Angioedema—Mometasone—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Lincomycin—Stomatitis—Leflunomide—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Lincomycin—Jaundice—Leflunomide—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Lincomycin—Leukocytosis—Prednisone—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Lincomycin—Abscess—Methotrexate—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Lincomycin—Hypotension—Pentoxifylline—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Lincomycin—Agranulocytosis—Leflunomide—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Lincomycin—Jaundice—Mycophenolic acid—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Lincomycin—Stomatitis—Mycophenolic acid—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Lincomycin—Pancytopenia—Lisinopril—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Lincomycin—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Lincomycin—Neutropenia—Lisinopril—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Lincomycin—Erythema multiforme—Azathioprine—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Lincomycin—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Lincomycin—Anaphylactic shock—Mometasone—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Lincomycin—Proteinuria—Methotrexate—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Lincomycin—Angioedema—Captopril—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Lincomycin—Protein urine present—Methotrexate—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Lincomycin—Erythema multiforme—Leflunomide—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Lincomycin—Jaundice—Lisinopril—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Lincomycin—Oesophagitis—Prednisone—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Lincomycin—Glossitis—Methotrexate—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Lincomycin—Oliguria—Methotrexate—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Lincomycin—Urticaria—Pentoxifylline—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Lincomycin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Lincomycin—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Lincomycin—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Lincomycin—Agranulocytosis—Lisinopril—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Lincomycin—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Lincomycin—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Lincomycin—Anaphylactic shock—Captopril—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Lincomycin—Thrombophlebitis—Prednisone—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Lincomycin—Vaginal inflammation—Methotrexate—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Lincomycin—Shock—Captopril—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Lincomycin—Pain—Mometasone—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Lincomycin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Lincomycin—Leukopenia—Azathioprine—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Lincomycin—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Lincomycin—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Lincomycin—Erythema multiforme—Lisinopril—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Lincomycin—Hypotension—Captopril—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Lincomycin—Pruritus—Pentoxifylline—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Lincomycin—Vaginal infection—Methotrexate—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Lincomycin—Tinnitus—Lisinopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Lincomycin—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Lincomycin—Angioedema—Leflunomide—systemic scleroderma	0.003	0.003	CcSEcCtD
Lincomycin—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Lincomycin—Vertigo—Leflunomide—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Lincomycin—Leukopenia—Leflunomide—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Lincomycin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Lincomycin—Body temperature increased—Mometasone—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Lincomycin—Abdominal pain—Mometasone—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Lincomycin—Vertigo—Mycophenolic acid—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Lincomycin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Lincomycin—Vomiting—Pentoxifylline—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Lincomycin—Rash—Pentoxifylline—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Lincomycin—Dermatitis—Pentoxifylline—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Lincomycin—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Lincomycin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Lincomycin—Hypotension—Azathioprine—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Lincomycin—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Lincomycin—Pruritus—Mometasone—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Lincomycin—Angioedema—Lisinopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Lincomycin—Abdominal pain—Captopril—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Lincomycin—Body temperature increased—Captopril—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Lincomycin—Nausea—Pentoxifylline—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Lincomycin—Vertigo—Lisinopril—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Lincomycin—Diarrhoea—Mometasone—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Lincomycin—Leukopenia—Lisinopril—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Lincomycin—Shock—Mycophenolic acid—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Lincomycin—Hypotension—Leflunomide—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Lincomycin—Hypotension—Mycophenolic acid—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Lincomycin—Vomiting—Mometasone—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Lincomycin—Rash—Mometasone—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Lincomycin—Dermatitis—Mometasone—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Lincomycin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Lincomycin—Pruritus—Captopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Lincomycin—Pain—Leflunomide—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Lincomycin—Shock—Lisinopril—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Lincomycin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Lincomycin—Neutropenia—Prednisone—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Lincomycin—Abdominal pain—Azathioprine—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Lincomycin—Body temperature increased—Azathioprine—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Lincomycin—Diarrhoea—Captopril—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Lincomycin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Lincomycin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Lincomycin—Nausea—Mometasone—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Lincomycin—Pain—Mycophenolic acid—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Lincomycin—Hypotension—Lisinopril—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Lincomycin—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Lincomycin—Urticaria—Leflunomide—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Lincomycin—Body temperature increased—Leflunomide—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Lincomycin—Abdominal pain—Leflunomide—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Lincomycin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Lincomycin—Vomiting—Captopril—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Lincomycin—Rash—Captopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Lincomycin—Dermatitis—Captopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Lincomycin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Lincomycin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Lincomycin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Lincomycin—Shock—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Lincomycin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Lincomycin—Pain—Lisinopril—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Lincomycin—Diarrhoea—Azathioprine—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Lincomycin—Nausea—Captopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Lincomycin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Lincomycin—Pancytopenia—Methotrexate—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Lincomycin—Pruritus—Leflunomide—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Lincomycin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Lincomycin—Neutropenia—Methotrexate—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Lincomycin—Diarrhoea—Leflunomide—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Lincomycin—Urticaria—Lisinopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Lincomycin—Body temperature increased—Lisinopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Lincomycin—Abdominal pain—Lisinopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Lincomycin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Lincomycin—Vomiting—Azathioprine—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Lincomycin—Rash—Azathioprine—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Lincomycin—Dermatitis—Azathioprine—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Lincomycin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Lincomycin—Stomatitis—Methotrexate—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Lincomycin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Lincomycin—Vomiting—Leflunomide—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Lincomycin—Hypersensitivity—Lisinopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Lincomycin—Rash—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Lincomycin—Dermatitis—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Lincomycin—Nausea—Azathioprine—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Lincomycin—Agranulocytosis—Methotrexate—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Lincomycin—Pruritus—Lisinopril—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Lincomycin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Lincomycin—Rash—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Lincomycin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Lincomycin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Lincomycin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Lincomycin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Lincomycin—Nausea—Leflunomide—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Lincomycin—Diarrhoea—Lisinopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Lincomycin—Angioedema—Prednisone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Lincomycin—Erythema multiforme—Methotrexate—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Lincomycin—Nausea—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Lincomycin—Vertigo—Prednisone—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Lincomycin—Tinnitus—Methotrexate—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Lincomycin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Lincomycin—Vomiting—Lisinopril—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Lincomycin—Rash—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Lincomycin—Dermatitis—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Lincomycin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Lincomycin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Lincomycin—Nausea—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Lincomycin—Anaphylactic shock—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Lincomycin—Shock—Prednisone—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Lincomycin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Lincomycin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Lincomycin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Lincomycin—Vertigo—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Lincomycin—Leukopenia—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Lincomycin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Lincomycin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Lincomycin—Urticaria—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Lincomycin—Abdominal pain—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Lincomycin—Body temperature increased—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Lincomycin—Hypotension—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Lincomycin—Hypersensitivity—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Lincomycin—Pain—Methotrexate—systemic scleroderma	0.000978	0.000978	CcSEcCtD
Lincomycin—Pruritus—Prednisone—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Lincomycin—Diarrhoea—Prednisone—systemic scleroderma	0.000936	0.000936	CcSEcCtD
Lincomycin—Urticaria—Methotrexate—systemic scleroderma	0.000909	0.000909	CcSEcCtD
Lincomycin—Body temperature increased—Methotrexate—systemic scleroderma	0.000904	0.000904	CcSEcCtD
Lincomycin—Abdominal pain—Methotrexate—systemic scleroderma	0.000904	0.000904	CcSEcCtD
Lincomycin—Vomiting—Prednisone—systemic scleroderma	0.00087	0.00087	CcSEcCtD
Lincomycin—Rash—Prednisone—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Lincomycin—Dermatitis—Prednisone—systemic scleroderma	0.000862	0.000862	CcSEcCtD
Lincomycin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Lincomycin—Nausea—Prednisone—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Lincomycin—Pruritus—Methotrexate—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Lincomycin—Diarrhoea—Methotrexate—systemic scleroderma	0.000783	0.000783	CcSEcCtD
Lincomycin—Vomiting—Methotrexate—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Lincomycin—Rash—Methotrexate—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Lincomycin—Dermatitis—Methotrexate—systemic scleroderma	0.00072	0.00072	CcSEcCtD
Lincomycin—Nausea—Methotrexate—systemic scleroderma	0.000679	0.000679	CcSEcCtD
